Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
The Journal of Clinical Psychiatry
|
March 12, 1999
Cost-utility analysis in schizophrenia
A G Awad, L P Voruganti
Acta Psychiatrica Scandinavica. Supplementum
|
June 10, 2005
Brain imaging research on subjective responses to psychotropic drugs
L P Voruganti, A G Awad
Psychological Reports
|
December 28, 1999
Psychiatric emergency rates during the Christmas season in the years 1991 to 1997
V R Velamoor, Z Z Cernovsky, L P Voruganti
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
April 6, 1999
Improving outcome in schizophrenia: the case for early intervention
A K Malla, R M Norman, L P Voruganti
Schizophrenia Research
|
August 31, 2007
Cognition, functioning and quality of life in schizophrenia treatment: results of a one-year randomized controlled trial of olanzapine and quetiapine
L P Voruganti, A G Awad, G Parker, et al.
Schizophrenia Research
|
September 4, 2007
Dysglycemia in a community sample of people treated for schizophrenia: the Diabetes in Schizophrenia in Central-South Ontario (DiSCO) study
L P Voruganti, Z Punthakee, R J Van Lieshout, et al.
Acta Psychiatrica Scandinavica
|
November 23, 2000
The relationship of symptoms and level of functioning in schizophrenia to general wellbeing and the Quality of Life Scale
R M Norman, A K Malla, T McLean, et al.
The American Journal of Psychiatry
|
March 18, 1999
Symptoms and cognition as predictors of community functioning: a prospective analysis
R M Norman, A K Malla, L Cortese, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
October 17, 1998
An integrated medical and psychosocial treatment program for psychotic disorders: patient characteristics and outcome
A K Malla, R M Norman, T S McLean, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
The Journal of Clinical Psychiatry
|
March 12, 1999
Cost-utility analysis in schizophrenia
A G Awad, L P Voruganti
Acta Psychiatrica Scandinavica. Supplementum
|
June 10, 2005
Brain imaging research on subjective responses to psychotropic drugs
L P Voruganti, A G Awad
Psychological Reports
|
December 28, 1999
Psychiatric emergency rates during the Christmas season in the years 1991 to 1997
V R Velamoor, Z Z Cernovsky, L P Voruganti
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
April 6, 1999
Improving outcome in schizophrenia: the case for early intervention
A K Malla, R M Norman, L P Voruganti
Schizophrenia Research
|
August 31, 2007
Cognition, functioning and quality of life in schizophrenia treatment: results of a one-year randomized controlled trial of olanzapine and quetiapine
L P Voruganti, A G Awad, G Parker, et al.
Schizophrenia Research
|
September 4, 2007
Dysglycemia in a community sample of people treated for schizophrenia: the Diabetes in Schizophrenia in Central-South Ontario (DiSCO) study
L P Voruganti, Z Punthakee, R J Van Lieshout, et al.
Acta Psychiatrica Scandinavica
|
November 23, 2000
The relationship of symptoms and level of functioning in schizophrenia to general wellbeing and the Quality of Life Scale
R M Norman, A K Malla, T McLean, et al.
The American Journal of Psychiatry
|
March 18, 1999
Symptoms and cognition as predictors of community functioning: a prospective analysis
R M Norman, A K Malla, L Cortese, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
October 17, 1998
An integrated medical and psychosocial treatment program for psychotic disorders: patient characteristics and outcome
A K Malla, R M Norman, T S McLean, et al.
Page
of 1